Dye Thomas J, Hantragool Sumalee, Carosella Christopher, Huang Guixia, Hossain Md M, Simakajornboon Narong
Division of Pulmonary and Sleep Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA; Division of Neurology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Division of Pulmonology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
Sleep Med. 2021 Mar;79:101-106. doi: 10.1016/j.sleep.2020.12.021. Epub 2020 Dec 29.
The effects of vagus nerve stimulation (VNS) on sleep disordered breathing (SDB) have been reported in limited case series. Detailed studies, particularly in the pediatric population, have not been performed. The primary purpose of this study is to describe clinical characteristics, polysomnographic findings, and management of children treated with VNS.
A retrospective review of medical records and polysomnography data was performed in patients ages 0-20 years old receiving VNS therapy for refractory epilepsy at Cincinnati Children's Hospital Medical Center.
22 subjects met the inclusion criteria. 50% were male. The mean age at the time of VNS insertion was 8.4 ± 4.0 years. The mean age at the first PSG was 10.6 ± 4.3 years. Common presentations to sleep clinics included snoring (77.3%), frequent nighttime awakening (68.1%), and parasomnias (63.6%). The median apnea-hypopnea index (AHI) was 4.5/hr (IQR 3.0-13.1) and the median obstructive index (OI) was 4.1/hr (1.5-12.8). Obstructive sleep apnea (OSA) was diagnosed after VNS insertion in 19 patients (86.4%), 8 of which (36.3%) had severe OSA. Six patients (27.3%) had significant hypoventilation. For management, 6 patients (27.2%) were treated with bilevel PAP, 3 patients (13.6%) with CPAP, 2 patients (9.1%) with ventilator, 4 patients (18.2%) with upper airway surgeries, and 9 patients (40.9%) received medications only.
SDB is common in pediatric patients with medically refractory epilepsy managed with VNS who were referred to sleep medicine clinics. Both OSA and nocturnal alveolar hypoventilation are relatively common in this population. Management of SDB often involves the use of positive airway pressure therapy or upper airway surgeries. Further studies are needed to assess the prevalence, risk factors, and the effect of treatments on epilepsy control. This study highlights the need for screening of SDB prior to and following VNS implantation.
在有限的病例系列中报道了迷走神经刺激(VNS)对睡眠呼吸障碍(SDB)的影响。尚未进行详细研究,尤其是在儿科人群中。本研究的主要目的是描述接受VNS治疗的儿童的临床特征、多导睡眠图结果及管理情况。
对辛辛那提儿童医院医疗中心接受VNS治疗难治性癫痫的0至20岁患者的病历和多导睡眠图数据进行回顾性分析。
22名受试者符合纳入标准。50%为男性。VNS植入时的平均年龄为8.4±4.0岁。首次多导睡眠图检查时的平均年龄为10.6±4.3岁。睡眠门诊的常见症状包括打鼾(77.3%)、夜间频繁觉醒(68.1%)和异态睡眠(63.6%)。呼吸暂停低通气指数(AHI)中位数为4.5次/小时(四分位间距3.0 - 13.1),阻塞性指数(OI)中位数为4.1次/小时(1.5 - 12.8)。19例患者(86.4%)在VNS植入后被诊断为阻塞性睡眠呼吸暂停(OSA),其中8例(36.3%)为重度OSA。6例患者(27.3%)存在明显的通气不足。在管理方面,6例患者(27.2%)接受双水平气道正压通气(bilevel PAP)治疗,3例患者(13.6%)接受持续气道正压通气(CPAP)治疗,2例患者(9.1%)使用呼吸机,4例患者(18.2%)接受上气道手术,9例患者(40.9%)仅接受药物治疗。
SDB在转诊至睡眠医学门诊、接受VNS治疗难治性癫痫的儿科患者中很常见。OSA和夜间肺泡通气不足在该人群中都相对常见。SDB的管理通常涉及使用气道正压治疗或上气道手术。需要进一步研究以评估患病率、危险因素以及治疗对癫痫控制的影响。本研究强调了在VNS植入前后筛查SDB的必要性。